Wedbush downgraded Raptor citing valuation following FDA approval of PROCYSBI. Price target lowered to $7 from $10.
Stocks closed about 1 percent higher on Thursday, led by tech shares, after weekly jobless claims figures pointed …
Raptor Pharmaceuticals downgraded to Neutral from Outperform at Wedbush
Theflyonthewall.com – 10 hours agoRELATED QUOTES
| Symbol | Price | Change |
|---|---|---|
| RPTP | 6.17 | -0.51 |
Related Content
- Analysts' Actions: AFL FFIV RJF SPWR WIN
- Analysts' Actions: AMGN BIIB DWA FCX ULTI
- Allergan price target lowered to $116 from $132 …
- Analysts' Actions: DIS MSG STI THC UNP
- Analysts' Actions: BEN CNX EXC REGN STX
- Analysts' Actions: BBY BWLD OXY PHM WAIR
- Short Story from Briefing.com
Is Old Tech, the New Opportunity Investment?CNBC Videos
Recent Quotes Symbol Price Change % Chg Chart Your most recently viewed tickers will automatically show up here if you type a ticker in the "Enter symbol/company" at the bottom of this module.Recent Quotes News
- Sign-in to view quotes in your portfolios.
- Wall Street closes up on tech gains, S&P near 1,600Reuters
Trading Center
Today on Yahoo!
1 - 6 of 48
Yahoo! Finance on Facebook
@YahooFinance on Twitter
POLL
Jobless claims fell to a 5-year low last week, sparking another rally. Do you believe the economy is back on solid footing?
Loading...